MiR-504 downregulation correlated with aggressive clinicopathological features and poor survival in glioma patients.
MiR-504 suppresses glioma tumorigenicity both in vitro and in vivo.
MiR-504 regulated glioma tumorigenesis by downregulating expression of its direct target, FOXP1.
MiR-504 might function as an important tumor suppressor of glioma tumorigenesis.